Periodontal disease might be a risk factor for graft versus host disease. A systematic review.

Graft versus host disease Periodontal disease Periodontitis Systematic review

Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 18 12 2018
revised: 03 12 2019
accepted: 17 01 2020
pubmed: 31 1 2020
medline: 25 3 2020
entrez: 31 1 2020
Statut: ppublish

Résumé

The aim of this systematic review was to determine a potential association between periodontal disease and graft versus host disease (GVHD). PubMed, Scopus and Web of Science databases were searched to identify all relevant articles. The eligibility criteria were prospective, retrospective, cross-sectional, cohort, case-control studies and interventional studies that assessed periodontal parameters in GVHD adults' patients. Seven studies, published between 2000 and 2018, were eligible. The aggravation of periodontal tissues is due to inadequate oral hygiene, dental plaque, decays, gum recession, retained roots, tooth loss, periodontally infected teeth. Several studies have indicated that periodontitis treatment performed before transplantation showed the reduction of gingival inflammation and maintenance of periodontal health. Periodontitis might be a risk factor for GVHD. However, due to the limited number of studies included in the review and their heterogeneity, more data are needed to sustain the correlation between periodontitis and GVHD.

Identifiants

pubmed: 32000068
pii: S1040-8428(20)30016-0
doi: 10.1016/j.critrevonc.2020.102878
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102878

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Alexandru Mester (A)

Department of Oral Health, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.

Alexandra Iulia Irimie (AI)

Department of Propedeutics, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.

Alina Tanase (A)

Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.

Sebastian Tranca (S)

Department of Intensive Care Unit, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.

Radu Septimiu Campian (RS)

Department of Oral Health, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.

Ciprian Tomuleasa (C)

Department of Hematology, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.

Delia Dima (D)

Department of Hematology, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.

Andra Piciu (A)

Department of Medical Oncology, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania. Electronic address: piciuandra@gmail.com.

Ondine Lucaciu (O)

Department of Oral Health, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH